首页> 美国卫生研究院文献>Journal of Clinical Microbiology >The L1 Major Capsid Protein of Human Papillomavirus Type 16 Variants Affects Yield of Virus-Like Particles Produced in an Insect Cell Expression System
【2h】

The L1 Major Capsid Protein of Human Papillomavirus Type 16 Variants Affects Yield of Virus-Like Particles Produced in an Insect Cell Expression System

机译:人类乳头瘤病毒16型变体的L1主要衣壳蛋白影响在昆虫细胞表达系统中产生的类似于病毒的颗粒的产量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The L1 major capsid proteins of six human papillomavirus type 16 (HPV-16) strains were expressed in insect cells by using recombinant baculoviruses. Virus-like particles (VLPs) which appeared similar to empty virions were identified by electron microscopy for all HPV strains investigated. However, the yield of VLPs produced varied in a range from 1 to 79 depending on the HPV-16 strain. The L1 proteins of these strains differed by up to 15 amino acids from the L1 protein of the prototype HPV-16 strain. Mutations in the amino acid region from residues 83 to 97 seemed to affect the level of expression of the L1 protein. These results are important when considering the development of HPV vaccines and serological tests. They indicate that strains inducing high levels of VLP production must be selected for the development of vaccines. Moreover, the L1 proteins of all strains investigated were able to bind with DNA. We also investigated the seroreactivities of VLPs derived from three different HPV-16 strains from Algeria, Senegal, and the Philippines by testing sera from women from 11 countries in immunoglobulin G-specific enzyme-linked immunosorbent assays. We observed a strong correlation between the reactivities of the three different VLP variants, independent of the geographical origin of the sera investigated. These results indicate that the three strains investigated are serologically cross-reactive despite the fact that their L1 proteins differ in 14 amino acids and suggest that VLPs derived from only one HPV-16 strain could be sufficient for the development of an HPV-16 vaccine and anti-HPV-16 tests.
机译:使用重组杆状病毒在昆虫细胞中表达了六种16型人乳头瘤病毒(HPV-16)菌株的L1主要衣壳蛋白。对于所有研究的HPV菌株,通过电子显微镜鉴定了看起来与空病毒体相似的病毒样颗粒(VLP)。然而,取决于HPV-16菌株,产生的VLP的产量在1至79的范围内变化。这些菌株的L1蛋白与原型HPV-16菌株的L1蛋白相差最多15个氨基酸。从残基83到97的氨基酸区域中的突变似乎影响L1蛋白的表达水平。当考虑开发HPV疫苗和血清学检测时,这些结果非常重要。他们表明,必须选择诱导高水平VLP产生的菌株来开发疫苗。而且,所有研究菌株的L1蛋白都能够与DNA结合。我们还通过在免疫球蛋白G特异性酶联免疫吸附试验中测试来自11个国家/地区的女性血清,研究了来自阿尔及利亚,塞内加尔和菲律宾的三种不同HPV-16菌株的VLP的血清反应活性。我们观察到三种不同VLP变体的反应性之间有很强的相关性,而与所研究血清的地理来源无关。这些结果表明,尽管这三个菌株的L1蛋白在14个氨基酸上存在差异,但它们在血清学上具有交叉反应性,这表明仅衍生自一种HPV-16菌株的VLP就足以开发出HPV-16疫苗,抗HPV-16测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号